# Neurocircuit Strategy to Decrease Cocaine Cue Reactivity

> **NCT04155632** · PHASE2 · COMPLETED · sponsor: **Medical University of South Carolina** · enrollment: 32 (actual)

## Conditions studied

- Cocaine-Related Disorders

## Interventions

- **DRUG:** N-acetylcysteine
- **DEVICE:** Theta-burst stimulation (TBS)

## Key facts

- **NCT ID:** NCT04155632
- **Lead sponsor:** Medical University of South Carolina
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-12-18
- **Primary completion:** 2023-03-09
- **Final completion:** 2023-03-09
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2025-09-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04155632

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04155632, "Neurocircuit Strategy to Decrease Cocaine Cue Reactivity". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04155632. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
